The neurosteroid 3α-hydroxy-5α-pregnan-20-one induces catalepsy in mice

Neuroscience Letters

Volumn 251, Issue 2, 1998, Pages 85-88

  Khisti, R T ^a   Mandhane, S N ^a   Chopde, C T ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

3 hydroxy 5 pregnan 20 one; Allopregnanolone; Catalepsy; Dopamine D2 receptor; GABA(A) receptor; Mice; Neurosteroid

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; AMINOOXYACETIC ACID; BICUCULLINE; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; HALOPERIDOL; MUSCIMOL; NEUROSTEROID; PICROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; EPILEPTOGENESIS; HORMONE ACTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATALEPSY; GABA MODULATORS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; PREGNANOLONE;

EID: 0032563146     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00479-0     Document Type: Article

References (23)

1. Alexander, G.E. and Crutcher, M.D., Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci., 13 (1990) 266-271.
2. Bartholini, G., Interaction of striatal dopaminergic, cholinergic and GABA-ergic neurons: relation to extrapyramidal function, Trends Pharmacol. Sci., 1 (1980) 138-140.
3. Bixo, M., Andersson, A., Winbald, B., Purdy, R.H. and Backstrom, T., Progesterone, 5α-pregnane-3, 20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states, Brain Res., 764 (1997) 173-178.
4. 2-dopamine receptor-mediated catalepsy, Brain Res., 450 (1988) 403-407.
5. Chen, S.W., Rodriguez, L., Davies, M.F. and Loew, G.H., The hyperphagic effect of 3α-hydroxylated pregnane steroids in male rats, Pharmacol. Biochem. Behav., 53 (1996) 777-782.
6. Chiodo, L.A., Caggiula, A.R. and Sailer, C.F., Estrogen increases both spiperone-induced catalepsy and brain levels of (3H)spiperone in the rat, Brain Res., 172 (1979) 360-366.
7. Dluzen, D.E. and Ramirez, V.D., Progesterone effects upon dopamine release from the corpus striatum of female rat. II. Evidence for a membrane site of action and the role of albumin, Brain Res., 476 (1989) 338-344.
8. 2+ channel current in freshly isolated hippocampal CA1 neurons, Eur. J. Pharmacol., 202 (1995) 269-273.
9. Finn, D.A., Phillips, T.J., Okorn, D.M., Chester, J.A. and Cunningham, C.L., Rewarding effect of neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in mice, Pharmacol. Biochem. Behav., 56 (1997) 261-264.
10. Floran, B., Floran, L., Sierra, A. and Aceves, J., D2 receptor mediated inhibition of GABA release by endogenous dopamine in rat globus pallidus, Neurosci. Lett., 237 (1997) 1-4.
11. Gee, K.W., McCauley, L.D. and Lan, N.C., A putative receptor for neurosteroids on GABAA receptor complex: the pharmacological properties and the therapeutic potential of epalons, Crit. Rev. Neurobiol., 9 (1995) 207-227.
12. Gruen, R.J., Friedhoss, A.J., Coale, A. and Moghaddam, B., Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABAA receptor antagonists on extracellular dopamine levels, Brain Res., 599 (1992) 51-56.
13. Haley, J.T. and McCormick, W.S., Pharmacological effects produced by intracerebral injections of drugs in conscious mouse, Br. J. Pharmacol., 12 (1957) 12-15.
14. LaLonde, R. and Botez, M.I., Subsensitivity to muscimol-induced catalepsy after long-term administration of phenytoin in rats, Psychopharmacology, 86 (1985) 77-80.
15. Nicolletti, R., Ferrara, N., Patti, F., Viglianese, M., Rampelle, L., Bianchi, A., Reggio, A. and Scapagnini, V., Influence of sex steroids and prolactin on haloperidol-induced catalepsy, Brain Res., 279 (1983) 352-358.
16. Pacitti, C., Fiadone, G., Gasbari, A., Civitelli, D. and Scarnati, E., Electrophysiological evidence for an inhibitory accumbens-entopenduncular pathway in the rat, Neurosci. Lett., 33 (1982) 35-50.
17. Paul, S.M. and Purdy, R.H., Neuroactive steroids, FASEB J., 6 (1992) 2311-2322.
18. Prince, R.J. and Simmonds, M.A., Steroid modulation of the strychnine-sensitive glycine receptor, Neuropharmacology, 31 (1992) 201-205.
19. Pycock, C.J. and Horton, R.W., Dopamine-dependent hyperactivity in rat following manipulation of GABA-mechanisms in the region of nucleus accumbens, J. Neural. Transm., 45 (1979) 17-33.
20. Pycock, C.J., Horton, R.W. and Marsden, C.D., The behavioral effects of manipulating GABA function in the globus pallidus, Brain Res., 116 (1976) 353-359.
21. Robel, P. and Baulieu, E.E., Neurosteroids: biosynthesis and function, Trends Endocrinol. Metab., 5 (1994) 1-8.
22. Santiago, M. and Westerink, B.H.C., The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats, Eur. J. Pharmacol., 219 (1992) 175-181.
23. Weilands, S., Lan, N.C., Mirasedeghi, S. and Gee, K.W., Anxiolytic activity of progesterone metabolite 3α-hydroxy-5α-pregnan-20-one, Brain Res., 565 (1991) 263-268.